Pertussis (Whooping Cough)
Pertussis, also known as whooping cough, is a highly contagious disease that is one of the leading causes of
vaccine-preventable deaths.
There are
30-150 million cases
per year, and about 300,000 deaths per year. Virtually all deaths occur in children under one year of age.
Ninety percent of all cases occur in developing countries. It is caused by certain species of the bacterium Bordetell; usually B. pertussis, but some cases are caused by B.
parapertussis.
The cough disease is characterized initially by mild respiratory infection symptoms such as cough, sneezing, and runny nose.
After one to two weeks the cough changes character, with paroxysms of coughing followed by an inspiratory
"whooping" sound. Coughing fits may be followed by vomiting, which in severe cases leads to malnutrition.
Coughing fits gradually diminish over one to two months. Other complications of the disease include pneumonia, encephalitis, pulmonary hypertension, and secondary bacterial superinfection.
The
whooping cough disease is spread by contact with airborne discharges from the mucous membranes of infected people.
Laboratory diagnosis include; Calcium alginate throat swab, culture on
Bordet-Gengou medium, immunofluorescence and serological methods.
Treatment of the disease with antibiotics (often erythromycin, azithromycin, clarithromycin or
trimethoprim-sulfamethoxazole) results in the person becoming less infectious but probably does not significantly alter the outcome of the disease.
Close contacts who receive appropriate antibiotics, "chemoprophylaxis", during the 7-21 day incubation period may be protected from developing symptomatic disease.
Whooping
cough pertussis vaccines were initially formulated in 1926; most notable by Dr. Louis W. Sauer of Northwestern University as
whole-cell preparations, but are now available as acellular preparations, which cause fewer side effects.
They offer protection for only a few years, and are given so that immunity lasts through childhood, the time of greatest exposure and greatest risk. The immunizations are often given in combination with tetanus and diphtheria immunizations, at ages 2, 4, and 6 months, and later at 15-18 months and 4-6 years.
Traditionally,
whooping cough pertussis vaccines are not given after age seven, as the frequency of side effects associated with the
whooping cough pertussis immunization increased with age.
The most serious
side-effects of
whooping cough pertussis immunization are neurological: they include seizures and hypotonic episodes.
An acellular vaccine preparation for older individuals is available in Canada and Europe, and two such products are being evaluated for their safety in adolescents and adults in the United States; a Food and Drug Administration decision is expected in 2005.
The disease is much milder in adults than in children and many cases go undiagnosed.
Source: for
whooping cough Pertussis: Public
Domain
Back to the Free tips on Healthcare Homepage

© Anthony George 2005 Whooping
Cough Pertussis Sponsor Love My Town
|